These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 12212064
21. Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity. Makovec F, Bani M, Chisté R, Revel L, Rovati LC, Rovati LA. Arzneimittelforschung; 1986; 36(1):98-102. PubMed ID: 3006713 [Abstract] [Full Text] [Related]
22. Measurement and characterization of neuronal cholecystokinin using a novel radioreceptor assay. Beresford IJ, Clark CR, Hughes J. Brain Res; 1986 Nov 29; 398(2):313-23. PubMed ID: 3801905 [Abstract] [Full Text] [Related]
23. Quantitative autoradiographic localization of cholecystokinin receptors in rat and guinea pig brain using 125I-Bolton-Hunter-CCK8. Niehoff DL. Peptides; 1989 Nov 29; 10(2):265-74. PubMed ID: 2755869 [Abstract] [Full Text] [Related]
24. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis. Barrett RW, Steffey ME, Wolfram CA. Mol Pharmacol; 1989 Apr 29; 35(4):394-400. PubMed ID: 2539554 [Abstract] [Full Text] [Related]
25. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM. Mol Pharmacol; 1989 Dec 29; 36(6):881-6. PubMed ID: 2601685 [Abstract] [Full Text] [Related]
26. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Smith JP, Rickabaugh CA, McLaughlin PJ, Zagon IS. Am J Physiol; 1993 Jul 29; 265(1 Pt 1):G149-55. PubMed ID: 8338163 [Abstract] [Full Text] [Related]
27. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors. Cappelli A, Anzini M, Vomero S, Menziani MC, De Benedetti PG, Sbacchi M, Clarke GD, Mennuni L. J Med Chem; 1996 Feb 16; 39(4):860-72. PubMed ID: 8632410 [Abstract] [Full Text] [Related]
28. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors. Schäfer U, Harhammer R, Boomgaarden M, Sohr R, Ott T, Henklein P, Repke H. J Neurochem; 1994 Apr 16; 62(4):1426-31. PubMed ID: 8133271 [Abstract] [Full Text] [Related]
29. Characteristics of 125I-Bolton-Hunter labelled cholecystokinin binding in human brain. Cross AJ, Slater P, Skan W. Neuropeptides; 1988 Apr 16; 11(2):73-6. PubMed ID: 3368039 [Abstract] [Full Text] [Related]
30. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor. Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP. J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851 [Abstract] [Full Text] [Related]
31. Discrimination between CCK receptors of guinea-pig and rat brain by cyclic CCK8 analogues. Durieux C, Pham H, Charpentier B, Roques BP. Biochem Biophys Res Commun; 1988 Aug 15; 154(3):1301-7. PubMed ID: 3408499 [Abstract] [Full Text] [Related]
32. A reduced pancreatic protein secretion in response to cholecystokinin (CCK) in the obese Zucker rat correlates with a reduced receptor capacity for CCK. Praissman M, Izzo RS. Endocrinology; 1986 Aug 15; 119(2):546-53. PubMed ID: 3015550 [Abstract] [Full Text] [Related]
33. Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas. Le Meuth V, Philouze-Rome V, Le Huerou-Luron I, Formal M, Vaysse N, Gespach C, Guilloteau P, Fourmy D. Endocrinology; 1993 Sep 15; 133(3):1182-91. PubMed ID: 8365360 [Abstract] [Full Text] [Related]
34. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Zhou W, Povoski SP, Longnecker DS, Bell RH. Cancer Res; 1992 Dec 15; 52(24):6905-11. PubMed ID: 1458479 [Abstract] [Full Text] [Related]
35. Novel localizations of central- and peripheral-type cholecystokinin binding sites in Syrian hamster brain as determined by autoradiography. Miceli MO, Steiner M. Eur J Pharmacol; 1989 Oct 10; 169(2-3):215-24. PubMed ID: 2806382 [Abstract] [Full Text] [Related]
36. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Moran TH, Smith GP, Hostetler AM, McHugh PR. Brain Res; 1987 Jul 07; 415(1):149-52. PubMed ID: 2441809 [Abstract] [Full Text] [Related]
37. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors. Rodriguez M, Lignon MF, Galas MC, Amblard M, Martinez J. Mol Pharmacol; 1990 Sep 07; 38(3):333-41. PubMed ID: 1698251 [Abstract] [Full Text] [Related]
38. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. Chang RS, Chen TB, Bock MG, Freidinger RM, Chen R, Rosegay A, Lotti VJ. Mol Pharmacol; 1989 Jun 07; 35(6):803-8. PubMed ID: 2733696 [Abstract] [Full Text] [Related]
39. Quinazolinone derivatives: synthesis and binding evaluation on cholecystokinin receptors. Varnavas A, Lassiani L, Luxich E, Zacchigna M, Boccù E. Farmaco; 1996 May 07; 51(5):333-9. PubMed ID: 8767843 [Abstract] [Full Text] [Related]
40. Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics. Hama Y, Ebadi M. Neurochem Res; 1987 Aug 07; 12(8):729-37. PubMed ID: 3627361 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]